vs
Acadia Healthcare Company, Inc.（ACHC）与Fair Isaac（FICO）财务数据对比。点击上方公司名可切换其他公司
Acadia Healthcare Company, Inc.的季度营收约是Fair Isaac的1.6倍（$829.0M vs $512.0M），Fair Isaac净利率更高（30.9% vs 0.5%，领先30.4%），Fair Isaac同比增速更快（16.4% vs 7.5%），过去两年Fair Isaac的营收复合增速更高（8.6% vs 2.0%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
FICO（原Fair, Isaac and Company）是美国知名数据分析企业，1956年由比尔·费尔与厄尔·艾萨克创立，总部位于蒙大拿州博兹曼市，核心业务为信用评分服务，其推出的FICO信用分是评估消费者信贷风险的重要指标，目前已被美国消费信贷行业广泛采用。
ACHC vs FICO — 直观对比
营收规模更大
ACHC
是对方的1.6倍
$512.0M
营收增速更快
FICO
高出8.8%
7.5%
净利率更高
FICO
高出30.4%
0.5%
两年增速更快
FICO
近两年复合增速
2.0%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $512.0M |
| 净利润 | $4.5M | $158.4M |
| 毛利率 | — | 83.0% |
| 营业利润率 | — | 45.7% |
| 净利率 | 0.5% | 30.9% |
| 营收同比 | 7.5% | 16.4% |
| 净利润同比 | -50.8% | 3.8% |
| 每股收益（稀释后） | $0.05 | $6.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCFICO
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $512.0M | ||
| Q3 25 | $851.6M | $515.8M | ||
| Q2 25 | $869.2M | $536.4M | ||
| Q1 25 | $770.5M | $498.7M | ||
| Q4 24 | $774.2M | $440.0M | ||
| Q3 24 | $815.6M | $453.8M | ||
| Q2 24 | $796.0M | $447.8M |
净利润ACHCFICO
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $158.4M | ||
| Q3 25 | $36.2M | $155.0M | ||
| Q2 25 | $30.1M | $181.8M | ||
| Q1 25 | $8.4M | $162.6M | ||
| Q4 24 | $32.6M | $152.5M | ||
| Q3 24 | $68.1M | $135.7M | ||
| Q2 24 | $78.5M | $126.3M |
毛利率ACHCFICO
| Q1 26 | — | — | ||
| Q4 25 | — | 83.0% | ||
| Q3 25 | — | 82.3% | ||
| Q2 25 | — | 83.7% | ||
| Q1 25 | — | 82.4% | ||
| Q4 24 | — | 80.1% | ||
| Q3 24 | — | 80.3% | ||
| Q2 24 | — | 80.3% |
营业利润率ACHCFICO
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 45.7% | ||
| Q3 25 | 4.7% | 46.0% | ||
| Q2 25 | 5.8% | 48.9% | ||
| Q1 25 | 1.7% | 49.3% | ||
| Q4 24 | 4.9% | 40.8% | ||
| Q3 24 | 12.1% | 43.4% | ||
| Q2 24 | 13.4% | 42.5% |
净利率ACHCFICO
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 30.9% | ||
| Q3 25 | 4.3% | 30.1% | ||
| Q2 25 | 3.5% | 33.9% | ||
| Q1 25 | 1.1% | 32.6% | ||
| Q4 24 | 4.2% | 34.7% | ||
| Q3 24 | 8.4% | 29.9% | ||
| Q2 24 | 9.9% | 28.2% |
每股收益（稀释后）ACHCFICO
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $6.61 | ||
| Q3 25 | $0.40 | $6.41 | ||
| Q2 25 | $0.33 | $7.40 | ||
| Q1 25 | $0.09 | $6.59 | ||
| Q4 24 | $0.36 | $6.14 | ||
| Q3 24 | $0.74 | $5.44 | ||
| Q2 24 | $0.85 | $5.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $162.0M |
| 总债务越低越好 | $2.5B | $3.2B |
| 股东权益账面价值 | $2.0B | $-1.8B |
| 总资产 | $5.5B | $1.9B |
| 负债/权益比越低杠杆越低 | 1.29× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCFICO
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $162.0M | ||
| Q3 25 | $118.7M | $134.1M | ||
| Q2 25 | $131.4M | $189.0M | ||
| Q1 25 | $91.2M | $146.6M | ||
| Q4 24 | $76.3M | $184.3M | ||
| Q3 24 | $82.1M | $150.7M | ||
| Q2 24 | $77.2M | $156.0M |
总债务ACHCFICO
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $3.2B | ||
| Q3 25 | $2.3B | $3.1B | ||
| Q2 25 | $2.3B | $2.8B | ||
| Q1 25 | $2.2B | $2.5B | ||
| Q4 24 | $2.0B | $2.4B | ||
| Q3 24 | $1.9B | $2.2B | ||
| Q2 24 | $1.8B | $2.1B |
股东权益ACHCFICO
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $-1.8B | ||
| Q3 25 | $3.1B | $-1.7B | ||
| Q2 25 | $3.1B | $-1.4B | ||
| Q1 25 | $3.0B | $-1.1B | ||
| Q4 24 | $3.1B | $-1.1B | ||
| Q3 24 | $3.0B | $-962.7M | ||
| Q2 24 | $3.0B | $-829.3M |
总资产ACHCFICO
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $1.9B | ||
| Q3 25 | $6.4B | $1.9B | ||
| Q2 25 | $6.3B | $1.9B | ||
| Q1 25 | $6.1B | $1.8B | ||
| Q4 24 | $6.0B | $1.7B | ||
| Q3 24 | $5.9B | $1.7B | ||
| Q2 24 | $5.7B | $1.7B |
负债/权益比ACHCFICO
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $174.1M |
| 自由现金流经营现金流 - 资本支出 | — | $173.9M |
| 自由现金流率自由现金流/营收 | — | 34.0% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 13.78× | 1.10× |
| 过去12个月自由现金流最近4个季度 | — | $750.6M |
8季度趋势，按日历期对齐
经营现金流ACHCFICO
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $174.1M | ||
| Q3 25 | $73.2M | $223.7M | ||
| Q2 25 | $133.5M | $286.2M | ||
| Q1 25 | $11.5M | $74.9M | ||
| Q4 24 | $116.7M | $194.0M | ||
| Q3 24 | $163.1M | $226.5M | ||
| Q2 24 | $171.1M | $213.3M |
自由现金流ACHCFICO
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $173.9M | ||
| Q3 25 | $-63.0M | $219.5M | ||
| Q2 25 | $-34.2M | $284.4M | ||
| Q1 25 | $-163.2M | $72.8M | ||
| Q4 24 | $-86.8M | $193.2M | ||
| Q3 24 | $-27.1M | $224.7M | ||
| Q2 24 | $16.9M | $211.6M |
自由现金流率ACHCFICO
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 34.0% | ||
| Q3 25 | -7.4% | 42.6% | ||
| Q2 25 | -3.9% | 53.0% | ||
| Q1 25 | -21.2% | 14.6% | ||
| Q4 24 | -11.2% | 43.9% | ||
| Q3 24 | -3.3% | 49.5% | ||
| Q2 24 | 2.1% | 47.2% |
资本支出强度ACHCFICO
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 0.0% | ||
| Q3 25 | 16.0% | 0.8% | ||
| Q2 25 | 19.3% | 0.3% | ||
| Q1 25 | 22.7% | 0.4% | ||
| Q4 24 | 26.3% | 0.2% | ||
| Q3 24 | 23.3% | 0.4% | ||
| Q2 24 | 19.4% | 0.4% |
现金转化率ACHCFICO
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 1.10× | ||
| Q3 25 | 2.02× | 1.44× | ||
| Q2 25 | 4.43× | 1.57× | ||
| Q1 25 | 1.37× | 0.46× | ||
| Q4 24 | 3.58× | 1.27× | ||
| Q3 24 | 2.39× | 1.67× | ||
| Q2 24 | 2.18× | 1.69× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
FICO
| Business To Business Scores | $248.6M | 49% |
| Saa S Products | $115.7M | 23% |
| Platform Software | $73.9M | 14% |
| Business To Consumer Scores | $55.9M | 11% |
| Technology Service | $19.2M | 4% |
